ADD THIS DRUG TO MY LIST

Select the drug indication to add to your list

EPIVIR-HBV
Viral infections
Compare To Related Drugs
View/Edit/Compare Drugs In My List

Only 4 drugs may be compared at once

Drug Name:

EPIVIR-HBV Rx

Generic Name and Formulations:
Lamivudine 100mg; tabs.

Company:
GlaxoSmithKline

Therapeutic Use:

Indications for EPIVIR-HBV:

Chronic hepatitis B associated with viral replication and active liver inflammation.

Adult:

100mg once daily. Renal impairment: CrCl 30–49mL/min: 100mg for 1st dose then 50mg once daily; CrCl 15–29mL/min: 100mg for 1st dose then 25mg once daily; CrCl 5–14mL/min: 35mg for 1st dose then 15mg once daily; CrCl <5mL/min: 35mg for 1st dose then 10mg once daily.

Children:

<2yrs: not recommended. 2–17yrs: 3mg/kg (max 100mg) once daily. Renal impairment: consider dose reduction.

Contraindications:

Concomitant zalcitabine.

Warnings/Precautions:

Unrecognized or untreated HIV infection (do HIV testing and counseling before and periodically during treatment). Not for treatment of HIV and HBV co-infections (use doses appropriate for HIV). Suspend if lactic acidosis or hepatotoxicity (eg, hepatomegaly and steatosis) occurs. Risk factors for liver disease. Women, obesity, or prolonged nucleoside exposure: increased risk of toxicity. Post-treatment exacerbation of hepatitis B; monitor closely during and for several months after treatment. Emergence of resistance-associated HBV substitutions: monitor ALT and HBV DNA levels during treatment. Diabetes (oral soln). Reevaluate annually. Pregnancy. Nursing mothers.

Interactions:

See Contraindications. Caution with drugs eliminated by active organic cationic secretion (eg, trimethoprim). Increased lamivudine absorption with TMP/SMX; increased zidovudine levels with lamivudine (clinical significance unknown).

See Also:

EPIVIR-HBV ORAL SOLUTION

Pharmacological Class:

Nucleoside analogue (reverse transcriptase inhibitor).

Adverse Reactions:

Ear, nose, and throat infections, sore throat, diarrhea; rare: lactic acidosis, severe hepatomegaly with steatosis, emergence of viral mutations.

Note:

Register pregnant patients exposed to lamivudine by calling (800) 258-4263.

Generic Availability:

Tabs (YES); Soln (NO)

How Supplied:

Tabs—60; Soln—240mL

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs